Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRG003 in EGFR-Positive Advanced Non-Small Cell Lung Cancer
NCT04838548Phase 2Completed
- Sponsor
- Lepu Biopharma Co., Ltd.
- Start
- Apr 2021
- Primary completion
- Mar 2023
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of becotatug vedotin in non-small cell lung cancer (NSCLC), sponsored by Lepu Biopharma Co., Ltd.. Started Apr 2021; status: completed.
02
Drugs
becotatug vedotin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04838548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04838548.